Vousden K H, Farrell P J
Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, London, UK.
Br Med Bull. 1994 Jul;50(3):560-81. doi: 10.1093/oxfordjournals.bmb.a072910.
Epstein-Barr virus (EBV), hepatitis B virus (HBV), HTLV-I and some human papillomaviruses (HPVs) appear to contribute to the development of a large proportion of certain human cancers. Although the epidemiological evidence linking infection with these viruses to malignancies is generally convincing, only for the HPVs have experimental systems indicated a clear role for some of the HPV encoded genes in tumour cell growth. In these cases, molecular analysis is revealing the mechanisms by which the virally encoded oncogenes function to perturb the normal regulation of cell growth. For HTLV-I, EBV and HBV the mechanism by which the viruses contribute to tumour cell growth is obscure, even though much has been learned about cell transformation in culture by these viruses. A detailed understanding of the mechanism of oncogenesis will be required to design therapeutic drugs for the treatment of these cancers. Prophylactic vaccination resulting in prevention of infection may be an effective approach to reduce the incidence of some of these common cancers.
爱泼斯坦-巴尔病毒(EBV)、乙型肝炎病毒(HBV)、人类嗜T淋巴细胞病毒I型(HTLV-I)以及某些人乳头瘤病毒(HPV)似乎在很大一部分特定人类癌症的发生发展中发挥作用。尽管将这些病毒感染与恶性肿瘤联系起来的流行病学证据总体上令人信服,但只有对于HPV,实验系统才表明某些HPV编码基因在肿瘤细胞生长中具有明确作用。在这些情况下,分子分析正在揭示病毒编码的癌基因干扰细胞生长正常调控的机制。对于HTLV-I、EBV和HBV,尽管已经对这些病毒在培养中的细胞转化有了很多了解,但病毒促进肿瘤细胞生长的机制仍不清楚。要设计治疗这些癌症的治疗药物,需要详细了解肿瘤发生的机制。预防性疫苗接种以预防感染可能是降低某些常见癌症发病率的有效方法。